By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: CoreWeave Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against CoreWeave, Inc. – CRWV
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Technology > CoreWeave Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against CoreWeave, Inc. – CRWV
CoreWeave Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of 0,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against CoreWeave, Inc. – CRWV
Technology

CoreWeave Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against CoreWeave, Inc. – CRWV

GlobeNews Wire
Last updated: 15/01/2026 10:38 AM
GlobeNews Wire
Published: 15/01/2026
Share
SHARE

NEW ORLEANS, Jan. 14, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against CoreWeave, Inc. (NasdaqGS: CRWV), if they purchased or otherwise acquired the Company’s securities between March 28, 2025 and December 15, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.

Get Help

CoreWeave investors should visit us at https://claimsfiler.com/cases/nasdaq-crwv/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit

CoreWeave and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company had overstated its ability to meet customer demand for its service; (ii) the Company materially understated the scope and severity of the risk that its reliance on a single third-party data center supplier created for its ability to meet customer demand for its services; (iii) the foregoing was reasonably likely to have a material negative impact on the Company’s revenue; and (iv) as a result, CoreWeave’s public statements were materially false and misleading at all relevant times.

The case is Masaitis v. CoreWeave, Inc., et al., No. 26-cv-00355.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

Delinea Receives Frost & Sullivan’s 2026 Global Technology Innovation Leadership Recognition for Innovation in Non-Human Identity Security
AlUla Contemporary Art Museum officially named at opening of pioneering exhibition Arduna
Xinhua Silk Road: Why UNESCO commends E. China’s Wenzhou twice within just half a month?
Renewable Energy Industry Veteran Jeff Tolnar Joins Hylenr’s Board of Directors
RadioMedix and Vect-Horus Announce First Patient Dosed in Exploratory Clinical Study of 203Pb-RMX-VH-PIB for Glioblastoma Multiforme and Pancreatic Ductal Adenocarcinoma
TAGGED:100,000actionAdventureagainstalert:claimsfilerclasscoreweavecrwvdeadlineexcessinc.investorslawsuit,leadlossesnewsplaintiffremindsshareholderwith
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
The Journey Continues: Accor’s Most Anticipated 2026 Openings
News

The Journey Continues: Accor’s Most Anticipated 2026 Openings

02/12/2025
U. S. Air Force Global Strike Command Reinstates the M18 Pistol
TricorBraun Releases 2024 Sustainability Report
Michelin-Star Chef Joakim Prat Joins Roast CCx to Bring French Pastry to Hyderabad
SEON Receives 2025 Global Enabling Technology Leadership Recognition from Frost & Sullivan
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?